Just diagnosed with small cell lung cancer? Learn why your first 48 hours matter, from understanding SCLC stages to exploring chemotherapy and clinical trials.

When treatment stops working, the clock starts moving fast. Patients with small cell lung cancer (SCLC) are often facing a diagnosis that’s aggressive, quick to spread, and can be resistant to lasting remission. SCLC accounts for approximately 15% of all lung cancer cases, yet it carries a disproportionately high burden of metastasis and relapse. Even […]

When diagnosed with cancer, one of the very first questions is often: What stage is it? Unlike many other cancers that are classified through stages I to IV, small cell lung cancer (SCLC) is most commonly grouped into two main categories: limited stage and extensive stage. This distinction plays a major role in how oncologists […]

In our recent webinar. Dr. Catherine Meador, thoracic oncologist and physician–scientist at Massachusetts General Hospital, shared insights on small cell lung cancer (SCLC) staging, treatment options, and side effects. Keep reading for a recap from the discussion. Watch the full webinar The following questions and responses have been lightly edited for grammatical purposes.  How does […]

We recently had the opportunity to speak with Dr. Charles Rudin, a leading lung cancer specialist and Deputy Director of the Cancer Center at Memorial Sloan Kettering Cancer Center, about small cell lung cancer (SCLC).  In part one, he explains what makes SCLC unique, how it’s typically treated, and what patients and caregivers should know […]

Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses or recommends any products or services. Consult your physician regarding any treatment or therapy. We had the privilege of hosting a one-hour Q&A with Dr. Charles Rudin, Deputy Director of the Cancer Center at Memorial Sloan Kettering and one of […]